Project Details
Description
Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients with Pulmonary Art
| Status | Finished |
|---|---|
| Effective start/end date | 1/31/06 → 5/22/13 |
Funding
- LILY ICOS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.